ストックスクリーナーアプリを入手
0.9795
0.67%
0.0065
アフターアワーズ：
.98
0.0005
+0.05%
前日終値:
$0.973
開ける：
$0.99
24時間の取引高:
43,707
Relative Volume:
0.03
時価総額：
$3.63M
収益：
-
当期純損益:
$-16.08M
株価収益率:
-0.4432
EPS:
-2.21
ネットキャッシュフロー:
$-11.54M
1週間 パフォーマンス:
-7.59%
1か月 パフォーマンス:
+12.46%
6か月 パフォーマンス:
-62.47%
1年 パフォーマンス:
-92.15%
1日の値動き範囲:
$0.902
$0.9994
1週間の範囲:
$0.90
$1.04
52週間の値動き範囲:
$0.846
$13.69
Bio Path Holdings Inc Stock (BPTH) Company Profile
名前
Bio Path Holdings Inc
セクター
電話
(832) 742-1357
住所
4710 BELLAIRE BOULEVARD, BELLAIRE, TX
Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-11 | 開始されました | ROTH Capital | Buy |
| 2017-11-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-10 | 繰り返されました | Maxim Group | Buy |
| 2016-04-18 | 開始されました | Rodman & Renshaw | Buy |
| 2014-06-02 | 再開されました | Maxim Group | Buy |
| 2014-05-09 | 開始されました | Maxim Group | Buy |
すべてを表示
Bio Path Holdings Inc (BPTH) 最新ニュース
Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com - Defense World
T-cell Malignancies Clinical Trial Pipeline Insights Featuring 70+ Companies | DelveInsight - The Malaysian Reserve
Antisense Oligonucleotide Therapeutics Market Poised for Significant Growth, Projected to Reach $64.64 Bill... - WhaTech
RNA Interference Therapy Competitive Landscape Report 2024 (Updated) - openPR
Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com - Defense World
RNA-based Therapeutics Market Latest Trends Analysis Report 2024 - InsightAce Analytic
siRNA Therapeutics Market Set for Explosive Growth, Projected to Reach $48.46 Billion by 2031 - WhaTech
80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港
siRNA Therapeutics Market Set for Explosive Growth, Expected to Hit $48.46 Billion by 2031 As Revealed In N... - WhaTech
Thyroid Cancer Drug Market to Exhibit a Remarkable CAGR of 17.2% - openPR
Chronic Myeloid Leukemia (CML) Treatment Market Report Analysis, Research Studies |Novartis AG, Bristol-Myers Squibb, Te – IndiaPolitics.com - IndiaPolitics.com
Antisense Oligonucleotide (ASO) Therapeutics Market Size, Share, and Future Growth Analysis (2024-2032) - News in Assen
Antisense and RNAi Therapeutics Market Growth, Share, and Industry Forecast (2024-2032) - News in Assen
New World Solutions (CSE: NEWS) (OTC: REGRF) Appoints Capital Markets Veteran Martin Tremblay to Board of Directors - Wall Street Reporter
Analytical Overview: Bio-Path Holdings Inc (BPTH)’s Ratios Tell a Financial Story - The Dwinnex
Bio-Path Holdings Raises $4M Through Private Placement - TipRanks
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Why this investor is skeptical about Tesla's robotaxi event - Yahoo Finance UK
Portfolio manager sees 'no landing' for US economy - Yahoo Finance UK
Russia to raise foreign company 'exit tax' to 35% from 15%, business daily reports - Yahoo Finance UK
Delta eyes Election Day travel pullback as profits climb - Yahoo Finance UK
Orient Green Power Shares Surge 7%, Outperform Sector Despite 'Strong Sell' Rating - Yahoo Finance UK
Prepare Yourself for Liftoff: Bio-Path Holdings Inc (BPTH) - SETE News
Dubai's DP World to use Hong Kong supply chain provider to connect China with the world - Yahoo Finance UK
Hungary central banker flags likely pause in rate cuts after forint falls - Yahoo Finance UK
Antisense Oligonucleotides Market Latest Sales Figure Signals More Opportunities Ahead - Elektrotransports.lv
Brookfield wins round Tritax Eurobox in £1.1bn tie-up - Yahoo Finance UK
London landlord GPE benefits from better investment conditions - Yahoo Finance UK
Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ... - Yahoo Finance
Bio-Path Holdings Inc [BPTH] Revenue clocked in at $0.00 million, down -87.15% YTD: What’s Next? - The DBT News
Analysts review Dayforce Inc’s rating - Knox Daily
Keeping an Eye on Bio-Path Holdings Inc (BPTH) After Insider Trading Activity - Knox Daily
NUBURU (NYSE: BURU) Partners with CDME at Ohio State University to Showcase the Unique Advantages of Blue Wavelength Lasers in Additive Manufacturing - Wall Street Reporter
MeridianLink Inc (MLNK) Becoming More Attractive for Investors - Knox Daily
Keeping an Eye on Exact Sciences Corp. (EXAS) After Insider Trading Activity - Knox Daily
Alector (ALEC) Stock Surges Over 5% Amid Positive Institutional Ratings - GuruFocus.com
BPTHBio-Path Holdings Inc Latest Stock News & Market Updates - StockTitan
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - ForexTV.com
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire Inc.
Walt Disney Company (DIS-N) QuotePress Release - The Globe and Mail
“Peraso Inc. (NASDAQ: PSRO) Pioneers mmWave Technology: The Next-Generation Wireless Communications” see bonus stocks inside….. - Barchart
Riot Platforms, Inc. (RIOT) Flat As Market Gains: What You Should Know - Yahoo Finance
"Peraso Inc. (NASDAQ: PSRO) Pioneers mmWave Technology: The Next-Generation Wireless Communications" see bonus stocks inside….. - WICZ
US Venture Capital Opens Path to Funding for China Biotech Firms - Yahoo Finance
Bluebird Bio (BLUE) Stock Dips Amid Market Volatility - GuruFocus.com
Allogene Therapeutics (ALLO) Sees 5% Stock Surge Amidst Biotech Sector Movement - GuruFocus.com
Wall Street-Heavily Traded - WDRB
Bio-Path Holdings Inc Inc. (BPTH) Price Performance: A Guide to Financial Ratios - The InvestChronicle
Nasdaq Surges Over 1%; DocuSign Shares Spike Higher - Benzinga
Bio-Path expands into obesity treatment with new program - Investing.com India
Understanding BPTH’s financial ratios: A beginner’s guide - US Post News
Bio Path Holdings Inc (BPTH) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):